Welcome, Guest
Username: Password: Remember me
PDSA Announcements
  • Page:
  • 1

TOPIC: Rigel's bleeding disorder drug clears first of two

Rigel's bleeding disorder drug clears first of two 2 years 6 months ago #55474

  • Jeff
  • Offline
  • I am the PDSA web guy, and also help with PDSA's social media accounts, like Facebook, Twitter, Instagram, etc.
  • Posts: 77
  • Karma: 1
  • Thank you received: 16
"The drug, fostamatinib, is being studied to treat chronic immune thrombocytopenia (ITP) in which the immune system attacks and destroys the body's own blood platelets.

About 18 percent of the 76 adult patients who were treated with fostamatinib achieved a stable platelet response in the study, compared with none on placebo.

Patients typically had an increase in platelet counts to a level above 50,000/uL within the initial weeks of treatment."

- From Reuters Health News

READ MORE
Jeff Cooper, PDSA website guy
The following user(s) said Thank You: Channer

Please Log in or Create an account to join the conversation.

  • Page:
  • 1

BBB Cleveland logo GuideStar Seal NORD Member Badge 2018THSNA logo